Application 091352
- Type
- ANDA
- Sponsor
- ZYDUS PHARMS USA INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | OMEPRAZOLE | OMEPRAZOLE | CAPSULE, DELAYED REL PELLETS;ORAL | 10MG | No | No |
| 002 | OMEPRAZOLE | OMEPRAZOLE | CAPSULE, DELAYED REL PELLETS;ORAL | 20MG | No | No |
| 003 | OMEPRAZOLE | OMEPRAZOLE | CAPSULE, DELAYED REL PELLETS;ORAL | 40MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A091352-001 | OMEPRAZOLE | OMEPRAZOLE | 10MG | CAPSULE, DELAYED REL PELLETS / ORAL | AB | 2012-11-19 | |
| A091352-002 | OMEPRAZOLE | OMEPRAZOLE | 20MG | CAPSULE, DELAYED REL PELLETS / ORAL | AB | 2012-11-19 | |
| A091352-003 | OMEPRAZOLE | OMEPRAZOLE | 40MG | CAPSULE, DELAYED REL PELLETS / ORAL | AB | 2012-11-19 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A091352-001 | AB |
| A091352-002 | AB |
| A091352-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A091352-001 | OMEPRAZOLE | 10MG | CAPSULE, DELAYED REL PELLETS / ORAL | AB | 2012-11-19 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A091352-002 | OMEPRAZOLE | 20MG | CAPSULE, DELAYED REL PELLETS / ORAL | AB | 2012-11-19 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A091352-003 | OMEPRAZOLE | 40MG | CAPSULE, DELAYED REL PELLETS / ORAL | AB | 2012-11-19 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A091352-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A091352-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A091352-003 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Omeprazole | OMEPRAZOLE | Major Pharmaceuticals | afda9d2c-b141-4c32-a5b4-e850974b30a3 | 2025-09-19 | Warnings, Adverse reactions | 091352 ANDA091352 0904-6917 |
| Omeprazole | OMEPRAZOLE | Cardinal Health 107, LLC | fbd71fd8-3f36-46a1-bc76-53f6820d42a2 | 2025-06-05 | Warnings, Adverse reactions | 091352 ANDA091352 55154-2332 |
| Omeprazole | OMEPRAZOLE | Zydus Lifesciences Limited | 2aaaf0fd-7f2a-4533-b3ad-f35c6c19cca2 | 2024-12-03 | 091352 ANDA091352 65841-761 65841-759 65841-760 | |
| Omeprazole | OMEPRAZOLE | A-S Medication Solutions | 9724601b-bb12-4eb2-bc2e-0532976bf5d1 | 2024-07-24 | Warnings, Adverse reactions | 091352 ANDA091352 |
| Omeprazole | OMEPRAZOLE | A-S Medication Solutions | 0ef8d55f-6cae-4b58-844b-968d8e5b8c24 | 2024-02-27 | Warnings, Adverse reactions | 091352 ANDA091352 |
| Omeprazole | OMEPRAZOLE | A-S Medication Solutions | 1c99e189-93c0-4461-82c2-4521e6c4d514 | 2024-02-27 | Warnings, Adverse reactions | 091352 ANDA091352 |
| Omeprazole | OMEPRAZOLE | Bryant Ranch Prepack | 39e3b45a-8e9b-49d6-976a-6668f4e27649 | 2023-07-10 | Warnings, Adverse reactions | 091352 ANDA091352 |
| Omeprazole | OMEPRAZOLE | Zydus Pharmaceuticals USA Inc. | 9c22ceb2-2c34-43c3-9a35-2589c9078741 | 2023-05-11 | Warnings, Adverse reactions | 091352 ANDA091352 68382-500 68382-411 68382-412 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0904-6917 | Omeprazole | Omeprazole | Major Pharmaceuticals | ANDA | Current |
| 0904-6917 | Omeprazole | Omeprazole | Major Pharmaceuticals | ANDA | Current |
| 0904-6917 | Omeprazole | Omeprazole | Major Pharmaceuticals | ANDA | Current |
| 55154-2332 | Omeprazole | Omeprazole | Cardinal Health | ANDA | Current |
| 55154-2332 | Omeprazole | Omeprazole | Cardinal Health | ANDA | Current |
| 55154-2332 | Omeprazole | Omeprazole | Cardinal Health | ANDA | Current |
| 55154-2332 | Omeprazole | Omeprazole | Cardinal Health 107, LLC | ANDA | Current |
| 55154-2332 | Omeprazole | Omeprazole | Cardinal Health | ANDA | Current |
| 65841-759 | Omeprazole | Omeprazole | Cadila Healthcare Limited | ANDA | Current |
| 65841-759 | Omeprazole | Omeprazole | Cadila Healthcare Limited | ANDA | Current |
| 65841-759 | Omeprazole | Omeprazole | Zydus Lifesciences Limited | ANDA | Current |
| 65841-759 | Omeprazole | Omeprazole | Cadila Healthcare Limited | ANDA | Current |
| 65841-760 | Omeprazole | Omeprazole | Cadila Healthcare Limited | ANDA | Current |
| 65841-760 | Omeprazole | Omeprazole | Cadila Healthcare Limited | ANDA | Current |
| 65841-760 | Omeprazole | Omeprazole | Zydus Lifesciences Limited | ANDA | Current |
| 65841-760 | Omeprazole | Omeprazole | Cadila Healthcare Limited | ANDA | Current |
| 65841-761 | Omeprazole | Omeprazole | Cadila Healthcare Limited | ANDA | Current |
| 65841-761 | Omeprazole | Omeprazole | Cadila Healthcare Limited | ANDA | Current |
| 65841-761 | Omeprazole | Omeprazole | Zydus Lifesciences Limited | ANDA | Current |
| 65841-761 | Omeprazole | Omeprazole | Cadila Healthcare Limited | ANDA | Current |
| 68382-411 | Omeprazole | Omeprazole | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 68382-411 | Omeprazole | Omeprazole | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 68382-411 | Omeprazole | Omeprazole | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 68382-411 | Omeprazole | Omeprazole | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 68382-411 | Omeprazole | Omeprazole | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 68382-411 | Omeprazole | Omeprazole | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 68382-411 | Omeprazole | Omeprazole | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 68382-412 | Omeprazole | Omeprazole | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 68382-412 | Omeprazole | Omeprazole | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 68382-412 | Omeprazole | Omeprazole | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 68382-412 | Omeprazole | Omeprazole | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 68382-412 | Omeprazole | Omeprazole | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 68382-412 | Omeprazole | Omeprazole | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 68382-412 | Omeprazole | Omeprazole | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 68382-500 | Omeprazole | Omeprazole | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 68382-500 | Omeprazole | Omeprazole | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 68382-500 | Omeprazole | Omeprazole | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 68382-500 | Omeprazole | Omeprazole | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 68382-500 | Omeprazole | Omeprazole | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 68382-500 | Omeprazole | Omeprazole | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 68382-500 | Omeprazole | Omeprazole | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |